Published in Cancer Weekly, January 14th, 2003
Results of this study were presented at the 44th annual meeting of the American Society of Hematology in Philadelphia.
"Researchers have been attempting to develop vaccines for cancer, including myeloid malignancies, for decades," according to Jeffrey Molldrem, MD, researcher from M.D. Anderson Cancer Center and study presenter. "We believe that the results of this pilot study show that...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.